Open access · CC-BY
via OpenAlex
Lysine Acetylation as a Regulatory Mechanism in Cardiometabolic Disease: A Focus on Sirtuins
Khushali Trivedi, Vernon Wayne Dolinsky
Pharmaceuticals · 2026
Abstract
Protein lysine acetylation is a widespread post-translational modification that regulates metabolic enzyme activity and cellular function. Sirtuins (SIRTs) are a family of nicotinamide adenine dinucleotide (NAD+)-dependent deacetylases that act as key metabolic sensors coupling cellular energy status to the regulation of protein acetylation. Dysregulation of sirtuin activity, particularly sirtuin 1 (SIRT1) and sirtuin 3 (SIRT3), has been implicated in the pathogenesis of cardiometabolic diseases, including obesity, type 2 diabetes, cardiovascular disease and metabolic dysfunction-associated steatotic liver disease. Under conditions of nutrient excess, alterations in acetyl-coenzyme A (acetyl-CoA) and NAD+ availability promote mitochondrial protein hyperacetylation, contributing to impaired mitochondrial respiration. Evidence from genetic and proteomic studies across metabolically active tissues such as the liver, heart, adipose tissue, skeletal muscle and pancreatic β-cells, highlight a central role for sirtuins in maintaining metabolic homeostasis. Therapeutic strategies aimed at improving mitochondrial function through activation of sirtuins have gained significant attention. Early studies focused on natural sirtuin activators, such as resveratrol and honokiol, while subsequent efforts led to the development of synthetic small-molecule activators, although their mechanisms of action remain debated. More recently, small molecule activators of SIRT1, such as SRT2104, and SIRT3, such as 2-acetyl-4-phenylquinoline (2-AQPC) and SZC-6 have been identified. In parallel, NAD+ augmenting through supplementation of NAD+ precursors such as nicotinamide riboside and nicotinamide mononucleotide has shown similar promising metabolic benefits in preclinical rodent models. Sirtuin-mediated lysine deacetylation represents a central mechanism regulating metabolic function and a promising target for therapeutic intervention in cardiometabolic disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ph19101557
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Trivedi, K., & Dolinsky, V.W. (2026). Lysine Acetylation as a Regulatory Mechanism in Cardiometabolic Disease: A Focus on Sirtuins. <em>Pharmaceuticals</em>. https://doi.org/10.3390/ph19101557
Vancouver
Trivedi K, Dolinsky VW. Lysine Acetylation as a Regulatory Mechanism in Cardiometabolic Disease: A Focus on Sirtuins. Pharmaceuticals. 2026. doi:10.3390/ph19101557.
BibTeX
@article{khushali2026Lysine,
title = {Lysine Acetylation as a Regulatory Mechanism in Cardiometabolic Disease: A Focus on Sirtuins},
author = {Khushali Trivedi and Vernon Wayne Dolinsky},
journal = {Pharmaceuticals},
year = {2026},
doi = {10.3390/ph19101557},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Pharmaceuticals (Basel, Switzerland) 2026
Open access · OA
Lysine Acetylation as a Regulatory Mechanism in Cardiometabolic Disease: A Focus on Sirtuins.
Journal of Obesity & Metabolic Syndrome 2023
Open access · CC-BY
Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Clinical and Translational Medicine 2016
Open access · CC-BY
Emerging therapeutic roles for NAD+ metabolism in mitochondrial and age‐related disorders
Frontiers in Physiology 2018
Open access · CC-BY
Acetylation of Mitochondrial Proteins in the Heart: The Role of SIRT3
Annals of the New York Academy of Sciences 2009
Preprint · OA
The Role of Sirtuins in the Control of Metabolic Homeostasis
IUBMB Life 2013
Open access · OA